Cryoport Insider Filing: CEO Adds 25,000 Shares, No Sales Reported
Rhea-AI Filing Summary
On 08/04/2025 Cryoport (CYRX) filed a Form 4 showing that President & CEO Jerrell Shelton exercised 25,000 stock options at an exercise price of $5 on 07/31/2025. This was a cash exercise with no subsequent sale of the underlying shares. As a result, Shelton’s direct holdings rose to 1,037,419 common shares.
The option was originally granted on 08/20/2015 and vested in equal monthly installments over 48 months; the filing confirms the award is now fully exercised and retired. The transaction modestly increases insider ownership and may indicate management confidence, but represents only about 2.4 % of Shelton’s total stake and does not involve open-market buying. No additional financial metrics, earnings data, or strategic commentary were included in the filing.
Positive
- CEO increased direct ownership by 25,000 shares, signalling continued commitment to the company.
- No shares were sold, eliminating near-term selling pressure and suggesting confidence in future performance.
Negative
- The transaction is small, adding only ~2.4 % to the CEO’s existing stake, limiting its signaling power.
- Shares were acquired via option exercise rather than open-market purchase, providing a weaker valuation signal.
Insights
TL;DR – CEO adds 25k shares via option exercise; no sale, modestly positive signal but limited market impact.
The cash exercise at $5 eliminates 25,000 fully-vested options and lifts Shelton’s direct stake to roughly 1.04 million shares. Lack of selling removes immediate supply pressure and can be interpreted as incremental confidence, yet the size is immaterial relative to his existing position and Cryoport’s 49 million basic shares outstanding. Because the shares were not bought on the open market, the purchase does not necessarily reflect valuation views. Overall impact on share price or valuation is expected to be neutral to mildly positive.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 25,000 | $0.00 | -- |
| Exercise | Common Stock | 25,000 | $5.00 | $125K |
Footnotes (1)
- This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015.